Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Lysophospholipid receptor nomenclature.

× No keyword cloud information.

14 in total

1. Rapid induction of medullary thymocyte phenotypic maturation and egress inhibition by nanomolar sphingosine 1-phosphate receptor agonist.

Authors: Hugh Rosen; Christopher Alfonso; Charles D Surh; Michael G McHeyzer-Williams
Journal: Proc Natl Acad Sci U S A Date: 2003-09-03 Impact factor: 11.205

2. Synthesis and biological evaluation of gamma-aminophosphonates as potent, subtype-selective sphingosine 1-phosphate receptor agonists and antagonists.

Authors: Frank W Foss; Ashley H Snyder; Michael D Davis; Michael Rouse; Mark D Okusa; Kevin R Lynch; Timothy L Macdonald
Journal: Bioorg Med Chem Date: 2006-11-01 Impact factor: 3.641

Review 3. A novel perspective on stem cell homing and mobilization: review on bioactive lipids as potent chemoattractants and cationic peptides as underappreciated modulators of responsiveness to SDF-1 gradients.

Authors: M Z Ratajczak; C H Kim; A Abdel-Latif; G Schneider; M Kucia; A J Morris; M J Laughlin; J Ratajczak
Journal: Leukemia Date: 2011-09-02 Impact factor: 11.528

4. Discovery, biological evaluation, and structure-activity relationship of amidine based sphingosine kinase inhibitors.

Authors: Thomas P Mathews; Andrew J Kennedy; Yugesh Kharel; Perry C Kennedy; Oana Nicoara; Manjula Sunkara; Andrew J Morris; Brian R Wamhoff; Kevin R Lynch; Timothy L Macdonald
Journal: J Med Chem Date: 2010-04-08 Impact factor: 7.446

5. Role of the G-protein-coupled receptor GPR12 as high-affinity receptor for sphingosylphosphorylcholine and its expression and function in brain development.

Authors: Atanas Ignatov; Julia Lintzel; Irm Hermans-Borgmeyer; Hans-Jürgen Kreienkamp; Patrick Joost; Susanne Thomsen; Axel Methner; H Chica Schaller
Journal: J Neurosci Date: 2003-02-01 Impact factor: 6.167

6. Lysophosphatidic acid attenuates the cytotoxic effects and degree of peroxisome proliferator-activated receptor gamma activation induced by 15-deoxyDelta12,14-prostaglandin J2 in neuroblastoma cells.

Authors: Helen A Rodway; Alan N Hunt; Janice A Kohler; Anthony D Postle; Karen A Lillycrop
Journal: Biochem J Date: 2004-08-15 Impact factor: 3.857

7. Inhibition of autotaxin production or activity blocks lysophosphatidylcholine-induced migration of human breast cancer and melanoma cells.

Authors: Cristoforo G Gaetano; Nasser Samadi; Jose L Tomsig; Timothy L Macdonald; Kevin R Lynch; David N Brindley
Journal: Mol Carcinog Date: 2009-09 Impact factor: 4.784

Review 8. Critical Role of the Sphingolipid Pathway in Stroke: a Review of Current Utility and Potential Therapeutic Targets.

Authors: Na Sun; Richard F Keep; Ya Hua; Guohua Xi
Journal: Transl Stroke Res Date: 2016-06-24 Impact factor: 6.829

9. Phosphorylation and desensitization of the lysophosphatidic acid receptor LPA1.

Authors: S Eréndira Avendaño-Vázquez; Agustín García-Caballero; J Adolfo García-Sáinz
Journal: Biochem J Date: 2005-02-01 Impact factor: 3.857

10. Lysophosphatidic acid modulates c-Met redistribution and hepatocyte growth factor/c-Met signaling in human bronchial epithelial cells through PKC delta and E-cadherin.

Authors: Yutong Zhao; Donghong He; Randi Stern; Peter V Usatyuk; Ernst Wm Spannhake; Ravi Salgia; Viswanathan Natarajan
Journal: Cell Signal Date: 2007-07-13 Impact factor: 4.315